Yahoo Web Search

    • Pharma M&A Deals Likely To Be Smaller in 2020

      GuruFocus.com via Yahoo Finance· 2 years ago

      Rather than acquisitions the size of Bristol-Myers Squibb's (BMY) $74 billion purchase of Celgene, Big Pharma will probably go after "bolt-ons" like Amgen's (AMGN) recent $13.4 billion purchase ...